Pharmaceutical

Where is the White House’s new pandemic response office?

Congress told the White House in December to create a new, permanent office to c...

Opinion: In a world of synthetic biology, publishing vi...

It is hard to imagine that a species that could figure out how to write, print a...

STAT+: With weight loss drug ads, telehealth companies ...

“In the old days, drug companies advertised prescription drugs, doctors prescrib...

Federal judge suspends FDA approval of abortion pill

A federal judge has suspended the FDA's approval of the abortion pill mifepristone.

STAT+: Digital health pioneer Pear Therapeutics files f...

The road has run out for Pear Therapeutics: the pioneering digital therapeutics ...

STAT+: Pharmalittle: Genentech finds no evidence of fra...

Genentech said a review of allegations concerning a paper co-authored by Marc Te...

STAT+: Liver disease researchers are hoping AI can impr...

Researchers hope that tools like ChatGPT could be useful in helping find targets...

STAT+: Wall Street embraces health insurers after scori...

Wall Street is embracing health insurers after they scored a big win for Medicar...

STAT+: A new AI tool aims to help surgeons quickly anal...

A new AI tool called DeepGlioma aims to give surgeons a real-time way to test br...

Opinion: I declined to share my medical data with adver...

Sharing health data with advertisers should be banned.

Verismo Therapeutics’ SynKIR-110 receives fast track de...

SynKIR-110 is an investigational drug to treat mesothelin-expressing mesotheliom...

ImmunoGen signs loan agreement with Pharmakon for up to...

The agreement will provide the company with additional capital for its growth tr...

Ginkgo buys StrideBio’s AAV discovery and engineering p...

Ginkgo will also receive StrideBio's existing library of capsids optimised for p...

Mirum applies for extended use of PFIC therapy in Europe

LIVMARLI showed maintenance of treatment effect with sustained decrease in serum...

RespireRx and UCL partner to study AMPAkines for GRIA D...

GRIA disorder is a family of rare genetic diseases triggered by mutations in the...

Singapore accepts Everest’s NDA for IgA nephropathy tre...

Everest’s NDA for Nefecon in China is anticipated to receive clearance by the se...